| Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy VR G Lonetto, G Koifman, A Silberman, A Attery, H Solomon, SL Zaidman, N ... Cell Death and Differentiation, 2018 | 32* | 2018 |
| Mouse eosinophil associated ribonucleases: Mechanism of cytotoxic, antibacterial and antiparasitic activities A Attery, JK Batra International journal of biological macromolecules 94, 445-450, 2017 | 18 | 2017 |
| Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis N Light, M Layeghifard, A Attery, V Subasri, M Zatzman, ND Anderson, ... Nature Communications 14 (1), 77, 2023 | 14 | 2023 |
| A ribonuclease inhibitor resistant dimer of human pancreatic ribonuclease displays specific antitumor activity A Attery, P Dey, P Tripathi, JK Batra International journal of biological macromolecules 107, 1965-1970, 2018 | 9 | 2018 |
| Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts H Agarwal, P Tal, N Goldfinger, E Chattopadhyay, D Malkin, V Rotter, ... Cell Death & Differentiation, 1-13, 2024 | | 2024 |
| Human eosinophil cationic protein manifests alarmin activity through its basicity and ribonuclease activity A Attery, I Saha, P Tailor, JK Batra bioRxiv, 2021.03. 24.436724, 2021 | | 2021 |
